Clinical application of circulating cell-free lymphoma DNA for fast and precise diagnosis of Burkitt lymphoma: Precision medicine for sub-Saharan Africa
Cambridge Prisms: Precision Medicine · 2023 · 1
DOI: 10.1017/pcm.2023.1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cambridge Prisms: Precision Medicine, online erschienen am 13.01.2023. Verfasst von Clara Chamba und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Muhimbili University of Health and Allied Science, Dar es Salaam, Tanzania. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Burkitt lymphoma (BL) has a cure rate of around 95% when treated with chemo-immunotherapy that is standard of care in high-income countries (Minard-Colin et al., 2020, New England Journal of Medicine 382, 2207–2219), but currently, more than 50% of children and young adults with endemic BL (Epstein Barr virus driven BL) in sub-Saharan Africa (SSA) do not survive. Treatment for BL is largely free of charge, but there is limited access to reliable diagnostic services leading to significant delays and misdiagnoses. Innovations in histopathology such as whole slide imaging and the use of novel diagnostic approaches, in particular using circulating cell-free viral and/or lymphoma DNA (liquid biopsy), could increase access to timely and reliable diagnosis and improve outcomes in SSA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Haematology, Muhimbili University of Health and Allied Science, Dar es Salaam, Tanzania.
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
- Department of Physiology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
- Department of Oncology, University of Oxford, Oxford, UK.
ORCID-Profile: Clara Chamba, Sam M Mbulaiteye
Zitieren
APA
Chamba, C., Mbulaiteye, S. M., Balandya, E., & Schuh, A. (2023). Clinical application of circulating cell-free lymphoma DNA for fast and precise diagnosis of Burkitt lymphoma: Precision medicine for sub-Saharan Africa. Cambridge Prisms: Precision Medicine, 1. https://doi.org/10.1017/pcm.2023.1
Vancouver
Chamba C, Mbulaiteye SM, Balandya E, Schuh A. Clinical application of circulating cell-free lymphoma DNA for fast and precise diagnosis of Burkitt lymphoma: Precision medicine for sub-Saharan Africa. Cambridge Prisms: Precision Medicine. 2023;1. doi:10.1017/pcm.2023.1
BibTeX
@article{Chamba2023,
author = {Chamba, Clara and Mbulaiteye, Sam M and Balandya, Emmanuel and Schuh, Anna},
title = {Clinical application of circulating cell-free lymphoma DNA for fast and precise diagnosis of Burkitt lymphoma: Precision medicine for sub-Saharan Africa},
journal = {Cambridge Prisms: Precision Medicine},
year = {2023},
volume = {1},
doi = {10.1017/pcm.2023.1}
}
EUVIMED